Cargando…
Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma
Dendritic cells (DCs) vaccine is a potential tool for oncoimmunotherapy. However, it is known that this therapeutic strategy has failed in solid tumors, making the development of immunoadjuvants highly relevant. Recently, we demonstrated that Phoneutria nigriventer spider venom (PnV) components are...
Autores principales: | de Mato, Felipe Cezar, Barreto, Natália, Cordeiro, Gabriel, Munhoz, Jaqueline, Bonfanti, Amanda Pires, da Rocha-e-Silva, Thomaz A. A., Sutti, Rafael, Cruz, Priscilla B. M., Sanches, Livia R., Bombeiro, André Luis, Chalbatani, Ghanbar Mahmoodi, Verinaud, Liana, Rapôso, Catarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092987/ https://www.ncbi.nlm.nih.gov/pubmed/37048096 http://dx.doi.org/10.3390/cells12071023 |
Ejemplares similares
-
Isolated Components From Spider Venom Targeting Human Glioblastoma Cells and Its Potential Combined Therapy With Rapamycin
por: Caballero, Marcus, et al.
Publicado: (2022) -
Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model
por: Bonfanti, Amanda Pires, et al.
Publicado: (2020) -
Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na(+)/K(+)-ATPase β2: potential molecular entities to treat invasive brain cancer
por: Barreto, Natália, et al.
Publicado: (2020) -
Purification and characterization of a hyaluronidase from venom of the spider Vitalius dubius (Araneae, Theraphosidae)
por: Sutti, Rafael, et al.
Publicado: (2014) -
Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives
por: Rapôso, Catarina
Publicado: (2017)